Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hajime Fujimoto

Showing results (41-50 of 117) with videos related to

Pageof 12
Sort By:
Journal of Cardiology|June 5, 2008
Primary and mid-term outcome of sirolimus-eluting stent implantation with angiographic guidance aloneHajime Fujimoto, Susumu Tao, Tomotaka Dohi, et al.
Respiratory Medicine Case Reports|April 16, 2025
Endobronchial tuberculosis mimicking malignancy: Lessons from a case reportTomohito Okano, Hajime Fujimoto, Toshiyuki Ito, et al.
The American Journal of Case Reports|January 8, 2025
Radiological and Pathological Analysis of Pembrolizumab-Associated Lung Lesions: Diagnostic Challenges and ManagementTomohito Okano, Hajime Fujimoto, Toshiyuki Ito, et al.
American Journal of Hematology|June 30, 2004
Increased circulating levels of thrombin-activatable fibrinolysis inhibitor in lung cancer patientsOsamu Hataji, Osamu Taguchi, Esteban Cesar Gabazza, et al.
European Heart Journal|October 31, 2007
Manganese superoxide dismutase polymorphism affects the oxidized low-density lipoprotein-induced apoptosis of macrophages and coronary artery diseaseHajime Fujimoto, Jun-Ichi Taguchi, Yasushi Imai, et al.
Journal of Cardiology|July 19, 2007
Use and long-term outcome of bare metal stent implantation in the drug-eluting stent eraHajime Fujimoto, Tomotaka Dohi, Jun Masuda, et al.
Experimental and Therapeutic Medicine|November 7, 2017
Smart watch-based coaching with tiotropium and olodaterol ameliorates physical activity in patients with chronic obstructive pulmonary diseaseOsamu Hataji, Yoichi Nishii, Kentaro Ito, et al.
Frontiers in Immunology|October 9, 2018
Role of Matrix Metalloproteinase-2 in Eosinophil-Mediated Airway RemodelingYu Kuwabara, Tetsu Kobayashi, Corina N D'Alessandro-Gabazza, et al.
Cancer Medicine|April 13, 2026
Endocrinologist-Led Management of Endocrine Immune-Related Adverse Events: Real-World Evidence Supporting the Japan Endocrine Society GuidelinesKota Nishihama, Hajime Fujimoto, Kanako Saito, et al.
American Journal of Respiratory and Critical Care Medicine|March 5, 2003
Thrombin-activatable fibrinolysis inhibitor and protein C inhibitor in interstitial lung diseaseHajime Fujimoto, Esteban Cesar Gabazza, Osamu Hataji, et al.
Pageof 12

Showing results (41-50 of 117) with videos related to

Sort By:
Pageof 12
Journal of Cardiology|June 5, 2008
Primary and mid-term outcome of sirolimus-eluting stent implantation with angiographic guidance aloneHajime Fujimoto, Susumu Tao, Tomotaka Dohi, et al.
Respiratory Medicine Case Reports|April 16, 2025
Endobronchial tuberculosis mimicking malignancy: Lessons from a case reportTomohito Okano, Hajime Fujimoto, Toshiyuki Ito, et al.
The American Journal of Case Reports|January 8, 2025
Radiological and Pathological Analysis of Pembrolizumab-Associated Lung Lesions: Diagnostic Challenges and ManagementTomohito Okano, Hajime Fujimoto, Toshiyuki Ito, et al.
American Journal of Hematology|June 30, 2004
Increased circulating levels of thrombin-activatable fibrinolysis inhibitor in lung cancer patientsOsamu Hataji, Osamu Taguchi, Esteban Cesar Gabazza, et al.
European Heart Journal|October 31, 2007
Manganese superoxide dismutase polymorphism affects the oxidized low-density lipoprotein-induced apoptosis of macrophages and coronary artery diseaseHajime Fujimoto, Jun-Ichi Taguchi, Yasushi Imai, et al.
Journal of Cardiology|July 19, 2007
Use and long-term outcome of bare metal stent implantation in the drug-eluting stent eraHajime Fujimoto, Tomotaka Dohi, Jun Masuda, et al.
Experimental and Therapeutic Medicine|November 7, 2017
Smart watch-based coaching with tiotropium and olodaterol ameliorates physical activity in patients with chronic obstructive pulmonary diseaseOsamu Hataji, Yoichi Nishii, Kentaro Ito, et al.
Frontiers in Immunology|October 9, 2018
Role of Matrix Metalloproteinase-2 in Eosinophil-Mediated Airway RemodelingYu Kuwabara, Tetsu Kobayashi, Corina N D'Alessandro-Gabazza, et al.
Cancer Medicine|April 13, 2026
Endocrinologist-Led Management of Endocrine Immune-Related Adverse Events: Real-World Evidence Supporting the Japan Endocrine Society GuidelinesKota Nishihama, Hajime Fujimoto, Kanako Saito, et al.
American Journal of Respiratory and Critical Care Medicine|March 5, 2003
Thrombin-activatable fibrinolysis inhibitor and protein C inhibitor in interstitial lung diseaseHajime Fujimoto, Esteban Cesar Gabazza, Osamu Hataji, et al.
Pageof 12